204 related articles for article (PubMed ID: 15664305)
21. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease.
Ninio E; Tregouet D; Carrier JL; Stengel D; Bickel C; Perret C; Rupprecht HJ; Cambien F; Blankenberg S; Tiret L
Hum Mol Genet; 2004 Jul; 13(13):1341-51. PubMed ID: 15115767
[TBL] [Abstract][Full Text] [Related]
22. Fenofibrate induces HDL-associated PAF-AH but attenuates enzyme activity associated with apoB-containing lipoproteins.
Tsimihodimos V; Kakafika A; Tambaki AP; Bairaktari E; Chapman MJ; Elisaf M; Tselepis AD
J Lipid Res; 2003 May; 44(5):927-34. PubMed ID: 12611907
[TBL] [Abstract][Full Text] [Related]
23. Serum platelet-activating factor acetylhydrolase activity: relationship with metabolic syndrome in women with history of gestational diabetes mellitus.
Derbent A; Kargili A; Koca C; Gümüş Iİ; Sevgili S; Simavli S; Karakurt F; Turhan NÖ
Gynecol Endocrinol; 2011 Feb; 27(2):128-33. PubMed ID: 20504094
[TBL] [Abstract][Full Text] [Related]
24. Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
Yamada A; Shoji T; Tahara H; Emoto M; Nishizawa Y
Metabolism; 2001 Jul; 50(7):805-11. PubMed ID: 11436186
[TBL] [Abstract][Full Text] [Related]
25. Maternal and fetal plasma platelet-activating factor acetylhydrolase activity and distribution in pre-eclampsia.
Fan P; Liu XH; He GL; Zhang S; Zhang JX; Bai H
Pediatr Res; 2012 Oct; 72(4):426-31. PubMed ID: 22797139
[TBL] [Abstract][Full Text] [Related]
26. Adenovirus-mediated gene transfer and lipoprotein-mediated protein delivery of plasma PAF-AH ameliorates proteinuria in rat model of glomerulosclerosis.
Iso-O N; Noto H; Hara M; Togo M; Karasawa K; Ohashi N; Noiri E; Hashimoto Y; Kadowaki T; Kimura S; Watanabe T; Tsukamoto K
Mol Ther; 2006 Jan; 13(1):118-26. PubMed ID: 16213192
[TBL] [Abstract][Full Text] [Related]
27. Urine of patients with nephrotic syndrome contains the plasma type of PAF-acetylhydrolase associated with lipoproteins.
Balafa OC; Karabina SA; Pappas CA; Elisaf M; Tselepis AD; Siamopoulos KC
Nephron Physiol; 2004; 97(3):p45-52. PubMed ID: 15292677
[TBL] [Abstract][Full Text] [Related]
28. Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS.
Bayrak T; Dursun P; Bayrak A; Gültekin M; Kolusarı A; Cakır E; Ozyurt M; Zeyneloğlu HB
Gynecol Endocrinol; 2012 Nov; 28(11):874-8. PubMed ID: 22621680
[TBL] [Abstract][Full Text] [Related]
29. Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in mice.
Singh U; Zhong S; Xiong M; Li TB; Sniderman A; Teng BB
Clin Sci (Lond); 2004 Apr; 106(4):421-32. PubMed ID: 14717654
[TBL] [Abstract][Full Text] [Related]
30. Effects of antihypertensive and hypolipidemic drugs on plasma and high-density lipoprotein-associated platelet activating factor-acetylhydrolase activity.
Tambaki AP; Rizos E; Tsimihodimos V; Tselepis AD; Elisaf M
J Cardiovasc Pharmacol Ther; 2004 Jun; 9(2):91-5. PubMed ID: 15309245
[TBL] [Abstract][Full Text] [Related]
31. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin.
Christidis DS; Liberopoulos EN; Kakafika AI; Miltiadous GA; Liamis GL; Kakaidi B; Tselepis AD; Cariolou MA; Elisaf MS
Arch Med Res; 2007 May; 38(4):403-10. PubMed ID: 17416287
[TBL] [Abstract][Full Text] [Related]
32. A single nucleotide polymorphism in the plasma PAF acetylhydrolase gene and risk of atherosclerosis in Japanese patients with peripheral artery occlusive disease.
Unno N; Sakaguchi T; Nakamura T; Yamamoto N; Sugatani J; Miwa M; Konno H
J Surg Res; 2006 Jul; 134(1):36-43. PubMed ID: 16650870
[TBL] [Abstract][Full Text] [Related]
33. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis.
Vadas P; Gold M; Perelman B; Liss GM; Lack G; Blyth T; Simons FE; Simons KJ; Cass D; Yeung J
N Engl J Med; 2008 Jan; 358(1):28-35. PubMed ID: 18172172
[TBL] [Abstract][Full Text] [Related]
34. Activity and distribution of plasma platelet-activating factor acetylhydrolase in women with gestational diabetes mellitus and their neonates.
Gao Q; He GL; Zhang L; Bai H; Liu XH; Fan P
Diabetes Metab Res Rev; 2016 Sep; 32(6):634-42. PubMed ID: 26789131
[TBL] [Abstract][Full Text] [Related]
35. Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factor acetylhydrolase and paraoxonase. Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis.
De Geest B; Stengel D; Landeloos M; Lox M; Le Gat L; Collen D; Holvoet P; Ninio E
Arterioscler Thromb Vasc Biol; 2000 Oct; 20(10):E68-75. PubMed ID: 11031226
[TBL] [Abstract][Full Text] [Related]
36. Platelet activating factor-acetylhydrolase (PAF-AH) activity and HDL levels, but not PAF-AH gene polymorphisms, are associated with successful aging in Sicilian octogenarians.
Campo S; Sardo MA; Trimarchi G; Bonaiuto A; Saitta C; Bitto A; Castaldo M; Cinquegrani M; Bonaiuto M; Cristadoro S; Saitta A
Aging Clin Exp Res; 2008 Apr; 20(2):171-7. PubMed ID: 18431085
[TBL] [Abstract][Full Text] [Related]
37. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106
[TBL] [Abstract][Full Text] [Related]
38. Ratio of LDL- to HDL-associated platelet-activating factor acetylhydrolase may be a marker of inflammation in patients with paroxysmal atrial fibrillation.
Okamura K; Miura S; Zhang B; Uehara Y; Matsuo K; Kumagai K; Saku K
Circ J; 2007 Feb; 71(2):214-9. PubMed ID: 17251670
[TBL] [Abstract][Full Text] [Related]
39. The differentiating effect of glimepiride and glibenclamide on paraoxonase 1 and platelet-activating factor acetylohydrolase activity.
Wójcicka G; Jamroz-Wiśniewska A; Marciniak A; Łowicka E; Bełtowski J
Life Sci; 2010 Jul; 87(3-4):126-32. PubMed ID: 20638992
[TBL] [Abstract][Full Text] [Related]
40. Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure.
Detopoulou P; Nomikos T; Fragopoulou E; Antonopoulou S; Kotroyiannis I; Vassiliadou C; Panagiotakos DB; Chrysohoou C; Pitsavos C; Stefanadis C
Clin Biochem; 2009 Jan; 42(1-2):44-9. PubMed ID: 18955040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
